BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 3, 2026
Breaking News: BioWorld Science 2025 Year in Review
See today's BioWorld Science
Home
» NAB-815 polymyxin derivative shows potential in preventing hemolytic uremic syndrome
To read the full story,
subscribe
or
sign in
.
Nephrology
NAB-815 polymyxin derivative shows potential in preventing hemolytic uremic syndrome
July 11, 2025
No Comments
Hemolytic uremic syndrome (HUS) is a severe condition that primarily affects young children and typically occurs after a gastrointestinal infection with Shiga toxin 2 (Stx2)-producing
Escherichia coli
(STEC).
BioWorld Science
Nephrology